X
    學術可視化工作室RC   登錄   提交文稿
學術英文編修

DRUG DELIVERY

期刊標題檢索 DRUG DELIV 最新評論: Submitted in May 25th, 25 years ago, with a bunch of ethical require... (2026-01-16)


期刊名稱:   ISSN:   主題領域:   影響因子範圍: -
索引:   類別:   開放訪問:   排序方式:

[DRUG DELIVERY]您好,您是該頁面的第 184322 位訪客。

期刊簡介
期刊名稱DRUG DELIVERY DRUG DELIVERY
LetPub Score
6.9
50 ratings
Rate

Reputation
7.7

Influence
6.2

Speed
8.4

期刊簡稱DRUG DELIV
ISSN1071-7544
E-ISSN1521-0464
h-index52
CiteScore
CiteScoreSJRSNIPCiteScore Rank
16.401.3801.265
Subject fieldQuartilesRankPercentile
Category: Pharmacology, Toxicology and Pharmaceutics
Subcategory: Pharmaceutical Science
Q17 / 185

自引率 (2023-2024)1.50%自引率趨勢
掲載範囲
Drug Delivery is an open access journal serving the academic and industrial communities with peer reviewed coverage of basic research, development, and application principles of drug delivery and targeting at molecular, cellular, and higher levels. Topics covered include all delivery systems including oral, pulmonary, nasal, parenteral and transdermal, and modes of entry such as controlled release systems; microcapsules, liposomes, vesicles, and macromolecular conjugates; antibody targeting; protein/peptide delivery; DNA, oligonucleotide and siRNA delivery. Papers on drug dosage forms and their optimization will not be considered unless they directly relate to the original drug delivery issues. Published articles present original research and critical reviews.
官方網站http://informahealthcare.com/drd
在線稿件提交https://mc.manuscriptcentral.com/udrd
開放訪問Yes
出版商Informa Healthcare
主題領域医学
出版國/地區UNITED STATES
發行頻率隔月刊行
創刊年1993
每年文章數40每年文章數趨勢
黃金OA百分比99.53%
OA Related Info
APC: Yes( EUR2875; USD2990; GBP2392; )
APC waiver:Check Notes
Other charges: No
Keywords: drug delivery systems、drug targeting、pharmaceutical sciences
Useful LinksAims & ScopeAuthor InstructionsEditorial BoardAnonymous peer review
Web of Science 四分位
2023-2024
WOS Quartile: Q1

CategoryEditionJIF QuartileJIF RankingJIF Percentage
PHARMACOLOGY & PHARMACYSCIEQ117/352
索引 (SCI or SCIE)Science Citation Index Expanded
鏈接到PubMed Central (PMC)https://www.ncbi.nlm.nih.gov/nlmcatalog?term=1071-7544%5BISSN%5D
平均審稿時間 *來自出版商的數據:
來自作者的數據: About 3.0 month(s)
競爭力 *來自作者的數據: Moderate
參考鏈接
相關期刊 【DRUG DELIVERY】CiteScore趨勢
自引率趨勢 每年文章數趨勢
作者評論
*所有的審稿過程指標,如接受率和審稿速度,僅限於用戶提交的稿件。因此,這些指標可能無法準確反映期刊的競爭力或速度。
  • 同一學科的期刊
  • CiteScore趨勢
  • 自引率趨勢
  • 每年文章數趨勢
  •  
    學科內的可信期刊 影響因子
    PHARMACOLOGICAL REVIEWSH-index: 210

    CiteScore: 34.00
    DRUG RESISTANCE UPDATESH-index: 100

    CiteScore: 23.20
    ADVANCED DRUG DELIVERY REVIEWSH-index: 278

    CiteScore: 36.00
    TRENDS IN PHARMACOLOGICAL SCIENCESH-index: 201

    CiteScore: 25.70
    PHARMACOLOGY & THERAPEUTICSH-index: 180

    CiteScore: 26.20
    MEDICINAL RESEARCH REVIEWSH-index: 119

    CiteScore: 29.50
    PHARMACOLOGICAL RESEARCHH-index: 118

    CiteScore: 18.60
    ARCHIVES OF PHARMACAL RESEARCHH-index: 75

    CiteScore: 14.40
    BIOMEDICINE & PHARMACOTHERAPYH-index: 78

    CiteScore: 12.80
    BRITISH JOURNAL OF PHARMACOLOGYH-index: 190

    CiteScore: 14.40
    學科內最受檢索的期刊 頁面查看次數
    PHARMACEUTICAL BIOLOGY23306516
    BIOMEDICINE & PHARMACOTHERAPY514391
    PHYTOMEDICINE474407
    LIFE SCIENCES414692
    European Journal of Pharmacology345318
    PHARMACOLOGICAL RESEARCH307374
    International Journal of Pharmaceutics277231
    BIOCHEMICAL PHARMACOLOGY275184
    JOURNAL OF NATURAL PRODUCTS204477
    BRITISH JOURNAL OF PHARMACOLOGY182289
  •  

    DRUG DELIVERY DRUG DELIVERY
    明年預測:
    穩步上升 無變化 逐步下降  刷新
  •  

     
  •  

     


首頁    上一頁    1    2    3    4    5    下一頁    末頁  (頁
/5)
  [DRUG DELIVERY] 的評論撰寫評論
作者: 天际润茁


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2018-01-14 14:35:29 評論於
Soon. Submission for revisions will be accepted in 40 days. Some might accept within 30 days. Usually, revisions are accepted on the same day or the next day. The OA fee is around $1600, but the quality of the articles varies
(0) 讚! | 天际润茁

作者: 1024309638@qq.com


領域: 医药科学
審稿時間: 1.0 month(s)
結果: 修改後接受


撰寫評論

2018-01-14 13:45:16 評論於
Quickly submitted for rework to receive 40 days and there are faster people who may accept within 30 days. Usually the modification is returned on the same day or the next day, the OA is received for about $1,600 but the quality of the article is uneven.
(0) 讚! | 1024309638@qq.com

作者: 是曼青吖


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2018-01-04 18:53:10 評論於
Submitted around 4 weeks ago, it was reviewed and rejected, with very constructive feedback from the reviewers
(0) 讚! | 是曼青吖

作者: 653692478@qq.com


領域: 医药科学
審稿時間: 2.0 month(s)
結果: 拒稿


撰寫評論

2018-01-04 12:05:33 評論於
submitted out for about 4 weeks, submitted for review, was rejected, the review comments are very fair
(1) 讚! | 653692478@qq.com

作者: cxaw


領域: 工程与材料
審稿時間: 2.0 month(s)
結果: 待定&不明


撰寫評論

2017-12-29 14:09:54 評論於
Impact factor will be greatly reduced?
(0) 讚! | cxaw

作者: 白云嘉珍


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2017-11-23 16:40:02 評論於
Review speed: 2.0 Experience sharing: "Under review" very quickly, in less than a month and a half. However, why haven't they notified about payment yet? The manuscript has already been published online, so why haven't they sent an email about payment
(0) 讚! | 白云嘉珍

作者: 中原文林


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2017-11-01 16:59:31 評論於
How long does it take for Under Review? Does it make a difference whether it is by the editor or external review?
(0) 讚! | 中原文林

作者: 仙灵增岳


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2017-10-13 11:42:10 評論於
Review speed: 1.0 | Submission acceptance rate: 25.0
Experience sharing: Fast review speed, high rejection rate, journal articles balancing novelty and practicality
(0) 讚! | 仙灵增岳

作者: 辉夜一莹


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2017-10-02 09:56:22 評論於
Review Speed: 2.0 | Acceptance Rate: 25.0
Sharing Experience: Focus more on clinical and basic research. Received more in the field of oncology. Reviews are faster but rejection rate is high. Acceptance rate is less than one third
(0) 讚! | 辉夜一莹

作者: 排云冬雪


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2017-09-18 22:00:44 評論於
Review speed: 1.0 | Submission acceptance rate: 75.0 Experience sharing: Just accepted a paper, it took 45 days, which is quite fast, but I haven't received the page fee notification for a week. Although I have been reminded that the journal needs to be paid, I am still waiting. I will let everyone know when there is any news
(0) 讚! | 排云冬雪

作者: 龙爪华丽


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2017-06-10 11:56:16 評論於
Do you need a layout fee? 
ligao posted on 2017-04-19: Submitted on March 8th, revised a month later, and accepted directly on April 17th! This speed is amazing and makes me feel so lucky!
(0) 讚! | 龙爪华丽

作者: 是你的建宇呀


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2017-04-29 21:01:21 評論於
Do you charge for the layout?
(0) 讚! | 是你的建宇呀

作者: 兰花樱花


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2017-04-19 20:11:50 評論於
Submitted on March 8th, minor revisions one month later, and accepted on April 17th! This speed is amazing and makes me feel very lucky!
(0) 讚! | 兰花樱花

作者: 兰花樱花


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2017-04-15 14:20:19 評論於
One month after submitting, the feedback received was minor revisions. Hoping for a positive outcome!
(0) 讚! | 兰花樱花

作者: 深渊逸翔


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2017-03-17 12:41:10 評論於
Efficient editing speed, minor revisions within 40 days after submission, returns within 15 days, and acceptance within 7 days
(0) 讚! | 深渊逸翔

作者: oph101@126.com


領域: 医药科学
審稿時間: 2.0 month(s)
結果: 修改後接受


撰寫評論

2017-03-17 02:54:06 評論於
Edit efficient speed, 40 days after submission, minor repair, 15 days return, 7 days after accepting
(0) 讚! | oph101@126.com

作者: 蒙德春花


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2016-12-14 17:01:05 評論於
Where can I find the submission link? hj2186 2016-03-16 Post:: Acceptance rate: Approximately 75% Review time: Approximately 1 month Reviewers are nice, but they require genuine and reliable results, and are quite detailed. The review process is relatively fast
(0) 讚! | 蒙德春花

作者: 美丽小公主


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2016-07-14 16:49:49 評論於
Hello, may I ask where can I find the submission link? 
hj2186 2016-03-16 published: Acceptance rate: about 75% Review time: about 1 month Reviewer is nice, but expects results to be real and reliable, and is quite detailed. The process is relatively fast
(0) 讚! | 美丽小公主

作者: 美丽小公主


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2016-07-14 11:53:47 評論於
Hello, may I ask where I can find the submission link? apollo1103 2015-10-30 Published: Research direction: drug delivery; Acceptance rate: about 50% Review time: about 2 months No page charges, the editor-in-chief is quite nice, and the in vivo results are relatively good
(0) 讚! | 美丽小公主

作者: 英歌baby


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2016-03-28 23:04:29 評論於
Hello everyone, I would like to know where to find the submission link. Thank you
(0) 讚! | 英歌baby

作者: 英歌baby


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2016-03-28 22:19:21 評論於
Have you found the submission link? I also want to submit to this magazine
(0) 讚! | 英歌baby

作者: 英歌baby


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2016-03-28 13:19:24 評論於
Can I ask if you have found the submission link? I also want to submit to this magazine
(0) 讚! | 英歌baby

作者: 一只语柳呀


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2016-03-16 23:53:09 評論於
Review Speed: 1.0 | Submission Acceptance Rate: 75.0
Experience Sharing: The reviewers are quite nice, but they require reliable and detailed results. The speed of review is relatively fast
(0) 讚! | 一只语柳呀

作者: 极乐玉淇


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2015-11-20 17:19:15 評論於
Hello, I would like to know where I can find the submission link. Thank you!
(0) 讚! | 极乐玉淇

作者: 千花灵慧


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2015-10-30 13:44:37 評論於
Review speed: 2.0 | Submission acceptance rate: 50.0
Sharing experience: No page charges, the chief editor is relatively nice, and the acceptance rate is better
(0) 讚! | 千花灵慧

首頁    上一頁    1    2    3    4    5    下一頁    末頁  (頁
/5)

開始撰寫 [DRUG DELIVERY] 的評論:





Contact us

Contact us  

Your name*

Your email*

Your message*

Please fill in all fields and provide a valid email.

Security Code*